Learn More
Sanfilippo syndrome is a mucopolysaccharidosis (MPS) caused by a lysosomal enzyme defect interrupting the degradation pathway of heparan sulfates. Affected children develop hyperactivity, aggressiveness, delayed development, and severe neuropathology. We observed relevant behaviors in the mouse model of Sanfilippo syndrome type B (MPSIIIB), in which the(More)
Pancreatic weight, [3H]-thymidine incorporation into DNA, labeling indices, and total DNA and RNA content were measured in rats treated with vehicle or 1 microgram/kg caerulein, 100 micrograms/kg secretin, or a combination of these peptides injected every 8 h for 1-5 days. Incorporation of [3H]thymidine into DNA increased 12-fold after 2 days of treatment(More)
This study was undertaken to determine the effect of reserpine on rat pancreatic growth, to evaluate if reserpine-caused alterations can be prevented by epidermal growth factor (EGF) and/or cerulein treatment, to evaluate the time course of rat pancreas recovery after reserpine, and to determine if EGF and/or cerulein treatment can accelerate such a(More)
Reserpine treatment resulted in altered enzyme secretion from rat pancreatic acini in response to carbamylcholine and secretin (1,2). This study was undertaken: (1) To evaluate if the alterations caused by reserpine can be prevented by EGF and/or cerulein treatments; (2) To determine the time-course of secretion recovery after reserpine treatment; and (3)(More)
  • 1